Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT00403533
Eligibility Criteria:
Inclusion Criteria:
* Patients with chronic HCV.
* Patients who need treatment for their elevated cholesterol:
* Total cholesterol \>240 or
* LDL \>160 without cardiac risk factors or
* LDL \>130 with two cardiac risk factors (hypertension, smoker, family history of heart attach, or HDL \<40 for men or \<50 for women) or
* LDL \>100 with diabetes or known coronary artery disease
Exclusion Criteria:
* Impaired mental ability preventing a subject from understanding the protocol or from completing the entire study.
* HCC
* A history of an adverse reaction to any HMG CoA reductase inhibitor.
* Patients who are on HCV treatment, who plan to initiate HCV treatment within 3 months, or who discontinued HCV treatment within the last 3 months.
* Patients whose aminotransferases are \> 5 times the upper limit of normal.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
80 Years
Study:
NCT00403533
Study Brief:
Protocol Section:
NCT00403533